title: Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients.
abstract: Clomipramine was significantly superior to placebo in a 10-week double-blind, placebo-controlled trial in 27 outpatients who met DSM-III-R criteria for obsessive-compulsive disorder.
authors.affiliation: Harvard Medical School and Massachusetts General Hospital, Boston 02114.
authors.forename: M A
authors.initials: MA
authors.lastname: Jenike
authors.forename: L
authors.initials: L
authors.lastname: Baer
authors.forename: P
authors.initials: P
authors.lastname: Summergrad
authors.forename: J B
authors.initials: JB
authors.lastname: Weilburg
authors.forename: A
authors.initials: A
authors.lastname: Holland
authors.forename: R
authors.initials: R
authors.lastname: Seymour
mesh_terms: D000328:Adult; D000553:Ambulatory Care; D002986:Clinical Trials as Topic; D002997:Clomipramine / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000523:psychology; D010919:Placebos; D011569:Psychiatric Status Rating Scales
chemical_list: D010919:Placebos; D002997:Clomipramine